ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

June 7, 2013

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

April 16, 2004

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004